Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00061945
Status:
COMPLETED
Last Update Posted:
2022-05-03
First Post:
2003-06-05
Brief Title:
Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Undifferentiated Leukemia |
| B-cell Adult Acute Lymphoblastic Leukemia |
| B-cell Childhood Acute Lymphoblastic Leukemia |
| L1 Adult Acute Lymphoblastic Leukemia |
| L1 Childhood Acute Lymphoblastic Leukemia |
| L2 Adult Acute Lymphoblastic Leukemia |
| L2 Childhood Acute Lymphoblastic Leukemia |
| Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia |
| Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia |
| T-cell Adult Acute Lymphoblastic Leukemia |
| T-cell Childhood Acute Lymphoblastic Leukemia |
| Untreated Adult Acute Lymphoblastic Leukemia |
| Untreated Childhood Acute Lymphoblastic Leukemia |
| Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia |
Keywords: